I-Minerals Halloysite to be Tested in New Wound Treatment Material
I-Minerals Inc. recently announced that its Ultra Hallopure halloysite is a key ingredient in the development of a new wound treatment material at the Institute of Diabetes Gerhardt Katsch Karlsburg (IDK). The new material uses a new impregnation technology developed by DURTEC GmbH of Neubrandenburg, Germany, wherein halloysite nanotubes (HNTs) can be “loaded” and then impregnated into textile fibers.
The IDK, in collaboration with DURTEC, designed the project and entered it in a biomedical competition hosted by the Government of Mecklenburg-Vorpommern. This project was elected and honored last year with a prize that included funding support of €200,000 (~ $226,242) for additional research.
“It is a pleasure and honor for our institute to be among the first researchers to test this new type of a halloysite nanotube-based medical device for wound treatment,” said Eckhard Salzsieder, Ph.D., IDK director. “We are optimistic for the outcome of our animal test program.”
“We are thrilled to have our Ultra Hallopure halloysite selected by a leading diabetes research institute for development of the wound treatment material,” said Tom Conway, CEO of I-Minerals Inc. “With competitor’s halloysite products containing cristobalite, higher heavy metals or a lower aspect ratio, this research helps position I-Minerals as a leading supplier to the life sciences market, and we see a great market potential in the future for several life science uses.”